Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT03326752 |
| Title | Phase 1b Dose Escalation and Dose Expansion Trial |
| Recruitment | Completed |
| Gender | both |
| Phase | Phase I |
| Variant Requirements | No |
| Sponsors | Dynavax Technologies Corporation |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Moores UC San Diego Cancer Center | La Jolla | California | 92093 | United States | Details | |
| Ronald Reagan University of California Los Angeles Medical Center | Santa Monica | California | 90404 | United States | Details | |
| Allina Health, Virginia Piper Cancer Institute | Minneapolis | Minnesota | 55407 | United States | Details | |
| Sarah Cannon Research Institute | Nashville | Tennessee | 37201 | United States | Details | |
| Virginia Cancer Specialists | Fairfax | Virginia | 22031 | United States | Details | |
| Seattle Cancer Care Alliance | Seattle | Washington | 98109 | United States | Details |